Background: Antimicrobial resistance (AMR) constitutes a major global public health challenge. Asymptomatic carriage of resistant organisms in children is particularly worrisome, as it may precede difficult-to-treat infections and facilitate the spread of resistance in both community and healthcare settings. Infections caused by multidrug-resistant organisms (MDROs) impose significant burdens on pediatric patients and their families, including extended hospital stays, psychological distress, and increased healthcare and socioeconomic costs. This review synthesizes current evidence on the prevalence and determinants of pediatric MDRO carriage, with an emphasis on community and community-associated settings, and identifies populations at increased risk to inform targeted surveillance and infection prevention strategies.
Methods: A narrative literature review was undertaken to examine MDRO carriage in pediatric populations, with particular emphasis on community and community-associated settings. The review encompassed pediatric studies published between 2016 and 2026, including studies investigating specific resistant organisms or resistance phenotypes, such as extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) and methicillin-resistant Staphylococcus aureus (MRSA), as well as studies addressing carriage in healthcare-associated and other high-risk groups. Studies were assessed according to population characteristics, setting, organisms investigated, prevalence, and associated determinants.
Learning Points: Reported MDRO carriage rates varied considerably among pediatric populations and settings. In a French community-based cohort of 1,886 children aged 6 to 24 months, the ESBL-E carriage rate was 7.6%. Among children attending daycare centers, ESBL-E carriage rates were 16% in Belgium and 6% in the Netherlands, while ciprofloxacin-resistant Enterobacterales carriage rates were 17% and 8%, respectively.
In hospitalized and other high-risk pediatric populations, overall MDRO carriage at hospital admission in Germany was 4.31% among 3,964 children, including multidrug-resistant Gram-negative bacteria, MRSA, and vancomycin-resistant Enterococci (VRE). In Pakistan, 68.3% of children admitted to a tertiary hospital were found to carry an MDRO, while in Greece, the rate was 22.5% among children admitted from the community to a pediatric intensive care unit. Among children with complex chronic conditions in Spain, multidrug-resistant Gram-negative bacterial carriage was identified in 27%. In Finland, 34.4% of 459 children screened after hospitalization abroad were colonized with an MDRO, predominantly ESBL-producing Enterobacterales.
Across studies, MDRO carriage was associated with prior antimicrobial exposure, hospitalization or healthcare contact, chronic or complex medical conditions, immunosuppression, surgical procedures, and international travel.
The wide range of reported prevalence estimates should not be interpreted as direct geographic comparisons, given differences in population selection, organisms studied, sampling sites, and microbiological methods. Collectively, these findings indicate that pediatric MDRO carriage is a significant and context-dependent challenge. This underscores the necessity for risk-adapted surveillance, targeted infection prevention, and antimicrobial stewardship, rather than reliance on a single prevalence estimate or universal risk profile.

